BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12385858)

  • 1. Lifetime estrogen exposure versus age at menopause as mortality predictor.
    Jansen SC; Temme EH; Schouten EG
    Maturitas; 2002 Oct; 43(2):105-12. PubMed ID: 12385858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.
    Marsh WK; Bromberger JT; Crawford SL; Leung K; Kravitz HM; Randolph JF; Joffe H; Soares CN
    Menopause; 2017 Dec; 24(12):1351-1359. PubMed ID: 28719421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis.
    Mishra SR; Chung HF; Waller M; Mishra GD
    BJOG; 2021 Apr; 128(5):809-821. PubMed ID: 32965759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study.
    Cui R; Iso H; Toyoshima H; Date C; Yamamoto A; Kikuchi S; Kondo T; Watanabe Y; Koizumi A; Inaba Y; Tamakoshi A;
    J Epidemiol; 2006 Sep; 16(5):177-84. PubMed ID: 16951536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ages at menarche and menopause, and mortality among postmenopausal women.
    Zhang X; Liu L; Song F; Song Y; Dai H
    Maturitas; 2019 Dec; 130():50-56. PubMed ID: 31706436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study.
    Jaspers L; Kavousi M; Erler NS; Hofman A; Laven JS; Franco OH
    Fertil Steril; 2017 Feb; 107(2):448-456.e1. PubMed ID: 27919437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women.
    de Kleijn MJ; van der Schouw YT; Verbeek AL; Peeters PH; Banga JD; van der Graaf Y
    Am J Epidemiol; 2002 Feb; 155(4):339-45. PubMed ID: 11836198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No added value of age at menopause and the lifetime cumulative number of menstrual cycles for cardiovascular risk prediction in postmenopausal women.
    Atsma F; van der Schouw YT; Grobbee DE; Hoes AW; Bartelink ML
    Int J Cardiol; 2008 Nov; 130(2):190-5. PubMed ID: 18063146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.
    Criqui MH; Suarez L; Barrett-Connor E; McPhillips J; Wingard DL; Garland C
    Am J Epidemiol; 1988 Sep; 128(3):606-14. PubMed ID: 3414664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women.
    Osei-Hyiaman D; Satoshi T; Ueji M; Hideto T; Kano K
    Am J Epidemiol; 1998 Dec; 148(11):1055-61. PubMed ID: 9850127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at menopause as a risk factor for cardiovascular mortality.
    van der Schouw YT; van der Graaf Y; Steyerberg EW; Eijkemans JC; Banga JD
    Lancet; 1996 Mar; 347(9003):714-8. PubMed ID: 8602000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies.
    Worzala K; Hiller R; Sperduto RD; Mutalik K; Murabito JM; Moskowitz M; D'Agostino RB; Wilson PW
    Arch Intern Med; 2001 Jun; 161(11):1448-54. PubMed ID: 11386895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime female hormonal exposure and risk of rheumatoid arthritis in postmenopausal women: Results from the French E3N cohort.
    Salliot C; Nguyen Y; Gelot A; Mariette X; Boutron-Ruault MC; Seror R
    Joint Bone Spine; 2022 Oct; 89(5):105374. PubMed ID: 35259476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual and reproductive factors and fracture risk: the Leisure World Cohort Study.
    Paganini-Hill A; Atchison KA; Gornbein JA; Nattiv A; Service SK; White SC
    J Womens Health (Larchmt); 2005 Nov; 14(9):808-19. PubMed ID: 16313208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative.
    Shadyab AH; Macera CA; Shaffer RA; Jain S; Gallo LC; Gass ML; Waring ME; Stefanick ML; LaCroix AZ
    Menopause; 2017 Jan; 24(1):35-44. PubMed ID: 27465713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of menopausal women: a survey of King and Pierce counties in Washington, 1973-2974.
    Stadel BV; Weiss N
    Am J Epidemiol; 1975 Sep; 102(3):209-16. PubMed ID: 1163526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual and reproductive factors and hip fractures in post menopausal women.
    Parazzini F; Tavani A; Ricci E; La Vecchia C
    Maturitas; 1996 Jul; 24(3):191-6. PubMed ID: 8844633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.